EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of β-hydroxybutyrate testing in ketogenic metabolic therapies

Cristina Fante, Franziska Spritzler, Lori Calabrese, Nicole Laurent, Caroline Roberts, Sofia Deloudi

Frontiers in Nutrition · 01.09.2025 · 12

DOI: 10.3389/fnut.2025.1629921 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 01.09.2025. Verfasst von Cristina Fante und 5 weiteren Autor:innen. Beteiligte Einrichtung: MetaboliCo GmbH, Bern, Switzerland. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate assessment of dietary adherence and metabolic outcomes remains a critical challenge in most nutrition studies. Ketogenic metabolic therapies (KMTs) provide a unique advantage by inducing nutritional ketosis and enabling the use of ketone bodies as biomarkers of metabolic state. This narrative review investigates the role of ketone testing as an integral component of KMTs. We introduce the key biomarkers and testing modalities currently used and present a comprehensive overview of the use of capillary blood β-hydroxybutyrate (BHB) testing across diverse therapeutic areas. Capillary blood BHB testing plays a multifaceted role in KMTs: it enables objective monitoring of dietary adherence, supports the interpretation of clinical outcomes, and informs personalized treatment adjustments based on individual metabolic responses. Additionally, it may facilitate behavior change through real-time feedback. Broader implementation of ketone testing in both clinical and research settings will require thoughtful protocol design that accounts for individual preferences and tolerability, continued technological innovation to enhance user experience, and further research into the relationship between ketone levels and therapeutic outcomes.

Schlagwörter

Stichwörter der Autor:innen

dietary adherenceketogenic dietketone testingnutritional ketosispatient empowermentpersonalized medicineβ-hydroxybutyrate

Autor:innen und Institutionen

  • MetaboliCo GmbH, Bern, Switzerland.
  • Keto-Check, Napa, CA, United States.
  • Touchpoints180™, South Windsor, CT, United States.
  • Family Renewal, Inc., Vancouver, WA, United States.
  • Virta Health, Denver, CO, United States.
  • Metabolic Health Consulting GmbH, Zurich, Switzerland.

Zitieren

APA

Fante, C., Spritzler, F., Calabrese, L., Laurent, N., Roberts, C., & Deloudi, S. (2025). The role of β-hydroxybutyrate testing in ketogenic metabolic therapies. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1629921

Vancouver

Fante C, Spritzler F, Calabrese L, Laurent N, Roberts C, Deloudi S. The role of β-hydroxybutyrate testing in ketogenic metabolic therapies. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1629921

BibTeX
@article{Fante2025,
  author = {Fante, Cristina and Spritzler, Franziska and Calabrese, Lori and Laurent, Nicole and Roberts, Caroline and Deloudi, Sofia},
  title = {The role of β-hydroxybutyrate testing in ketogenic metabolic therapies},
  journal = {Frontiers in Nutrition},
  year = {2025},
  volume = {12},
  doi = {10.3389/fnut.2025.1629921}
}
Kostenlos starten →